3 studies found for:    19236279 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
2 Active, not recruiting
Has Results
Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015)
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine;   Biological: Matching Placebo
3 Completed
Has Results
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501;   Biological: Comparator: Placebo;   Biological: Human Papillomavirus (HPV) 16 Monovalent

Indicates status has not been verified in more than two years